Aurinia Pharmaceuticals (AUPH) Selling, General & Administrative (2020 - 2026)
Aurinia Pharmaceuticals' Selling, General & Administrative was $23.51 million in Q2 2026, down 9.6% from $26.02 million a year earlier but up 6.7% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Selling, General & Administrative (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aurinia Pharmaceuticals' Selling, General & Administrative was $100.97 million through Jun 30, 2026, down 19.7% year-over-year; for FY2025, it was $101.79 million, down 40.8% from FY2024.
- Selling, General & Administrative has now declined for three consecutive years, though with a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $172.03 million in FY2024 (-11.8%), $195.04 million in FY2023 (-0.7%), $196.37 million in FY2022 (+13.2%) and $173.54 million in FY2021 (+78.4%).
- Quarterly Selling, General & Administrative has moved between $20.34 million (Q1 2025) and $52.17 million (Q3 2022) over five years.
- Compared with a year earlier, Selling, General & Administrative was higher in 1 of the last eight quarters, with an average decline of 24.7%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 45.4%); the worst was Q1 2025 (a decline of 57.4%).
- Per Business Quant data, AUPH's Selling, General & Administrative in the three quarters before Q2 2026 was $22.03 million (Q1 2026), $29.26 million (Q4 2025) and $26.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Aurinia Pharmaceuticals | 2.12 Bn | 548.16 Mn | 76.67 Mn | 23.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.51 Mn |
| Mar 31, 2026 | 22.03 Mn |
| Dec 31, 2025 | 29.26 Mn |
| Sep 30, 2025 | 26.18 Mn |
| Jun 30, 2025 | 26.02 Mn |
| Mar 31, 2025 | 20.34 Mn |
| Dec 31, 2024 | 37.03 Mn |
| Sep 30, 2024 | 42.37 Mn |
| Jun 30, 2024 | 44.93 Mn |
| Mar 31, 2024 | 47.70 Mn |
| Dec 31, 2023 | 50.07 Mn |
| Sep 30, 2023 | 47.76 Mn |
| Jun 30, 2023 | 47.08 Mn |
| Mar 31, 2023 | 50.12 Mn |
| Dec 31, 2022 | 47.47 Mn |
| Sep 30, 2022 | 52.17 Mn |
| Jun 30, 2022 | 51.53 Mn |
| Mar 31, 2022 | 45.20 Mn |
| Dec 31, 2021 | 44.76 Mn |
| Sep 30, 2021 | 44.65 Mn |
API Access
Aurinia Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();